Posted November 4, 2020
Remdesivir, the drug that had almost no effect on COVID mortality, has been FDA-approved to treat COVID. Action Alert! Remdesivir was touted by the government for months as the new “standard of care” before being the first treatment to receive FDA-approval to treat COVID. While the drug has been shown to reduce the hospital stays of patients with mild to severe COVID-19 cases from 15 days to 10 days, a large World Health Organization study led researchers to conclude that the drug has “little or no effect on mortality.” Read more.